| Jan 8 2019 |
FDA 2018 Year in Review: Cannabis |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Tobacco |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Medical Devices |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Drug Supply Chain Security Act |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Advertising and Promotion |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Food |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Drug Quality Security Act Implementation |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Drugs |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
New Canadian Food Safety Law Takes Effect in One Week |
Keller and Heckman LLP |
| Jan 8 2019 |
DC District Court Holds that Medicare Payment Cuts for 340B Drugs Exceeded Agency’s Authority |
Foley & Lardner LLP |
| Jan 8 2019 |
California Legislature Mulls Cannabis Bank Charters |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
| Jan 7 2019 |
Promising Results of Aurodox Study Suggest Potential Treatment for E. coli Infection |
Keller and Heckman LLP |
| Jan 7 2019 |
“Pathways to Success:” CMS Publishes Final Rule Modifying the Medicare Shared Savings Program |
Foley & Lardner LLP |
| Jan 7 2019 |
FTA and USCG Raise Random Drug Testing Rates to 50% for 2019 |
Jackson Lewis P.C. |
| Jan 4 2019 |
CBD Use in the Workplace: Resolving State And Federal Law Conflicts |
Barnes & Thornburg LLP |
| Jan 4 2019 |
State Marijuana Laws vs. Bankruptcy: The Tension Grows |
Squire Patton Boggs (US) LLP |
| Jan 4 2019 |
USDA Publishes Final Rule Amending the National List of Allowed and Prohibited Substances for Organic Handling or Production |
Keller and Heckman LLP |
| Jan 3 2019 |
Data Privacy and Security in the Cannabis Industry |
Robinson & Cole LLP |
| Jan 3 2019 |
2018 Year-End FDA Medical Device Highlights Include Proposed Changes |
Barnes & Thornburg LLP |
| Jan 3 2019 |
FDA, USDA Impacted by Lapse in Government Funding |
Keller and Heckman LLP |
| Jan 3 2019 |
Cheez-Its Class Action Revived in “Whole” by Second Circuit |
Proskauer Rose LLP |
| Jan 2 2019 |
Connecticut Court Rules in Favor of Medical Marijuana User in Discrimination Case |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jan 2 2019 |
In Light of 2018 Farm Bill, FDA Issues Statement on Use of CBD in Food; Completes Evaluation of 3 Hemp-Related GRASNs |
Keller and Heckman LLP |
| Dec 28 2018 |
USDA AMS National Bioengineered (BE) Food Disclosure Standard Final Rule |
Keller and Heckman LLP |
| Dec 28 2018 |
Nipped in the Bud: Massachusetts Regulators Send Strong Message to Cannabis Industry About Using Unapproved Pesticides On Cannabis Plants |
Beveridge & Diamond PC |
| Dec 27 2018 |
Standards for Use of Opiates in Treatment of Pain Changes in Ohio |
Dinsmore & Shohl LLP |
| Dec 27 2018 |
Supplement Company Settles with FTC Over Diabetes Pill Marketing Claims |
Keller and Heckman LLP |
| Dec 27 2018 |
California Court of Appeal Rejects ABC Interpretation of “Single Beverage Condition” |
Mitchell Silberberg & Knupp LLP |
| Dec 26 2018 |
2018 Farm Bill Legalizes Industrial Hemp |
Beveridge & Diamond PC |
| Dec 24 2018 |
The Year in Weed and CBD 2018 |
Hinch Newman LLP |
| Dec 22 2018 |
Appropriations Continuing Resolution Passed by the Senate on December 19, 2018, Extends PRIA through February 8, 2019 |
Bergeson & Campbell, P.C. |
| Dec 21 2018 |
FDA Updates Its Position on CBD upon Signing of Farm Bill |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Dec 21 2018 |
DOE Announces Funding Opportunities and Requests Information on Feedstocks |
Bergeson & Campbell, P.C. |
| Dec 21 2018 |
$15 Million False Ad Verdict Boosts Damages In Probiotic IP Dispute |
Proskauer Rose LLP |
